1-20 of 25
Christophe Bonnet
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of Primary Mediastinal B-Cell Lymphoma Patients Treated with a PET-Guided Strategy in the Randomized Phase 3 Gained Study Conducted By Lysa

Vincent Camus, Thierry Jo Molina, Fabienne Desmots-Loyer, Amine Moslemi, Philippe Ruminy, Steven Le Gouill, Herve Ghesquieres, Lucie Oberic, Franck Morschhauser, Hervé Tilly, Vincent Ribrag, Roch Houot, Catherine Thieblemont, Herve Maisonneuve, Fabien Claves, Krimo Bouabdallah, Corinne Haioun, Gandhi Damaj, Luc-Matthieu Fornecker, Robin Noel, Pierre Feugier, David Sibon, Guillaume Cartron, Christophe Bonnet, Marc André, Françoise Kraeber-Bodéré, Caroline Milin, Jean-Philippe Jais, Josette Briere, Olivier Casasnovas, Salim Kanoun, Emmanuel Itti, Paul Blanc-Durand, Mad-Hélénie Elsensohn, Loic Chartier, Fabrice Jardin, Thierry Fest
Journal: Blood
Blood (2024) 144 (Supplement 1): 575.
https://doi.org/10.1182/blood-2024-202446
Published: 2024
Journal Articles

The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients

Clinical Trials & Observations
Hervé Ghesquières, Daphné Krzisch, Emmanuelle Nicolas-Virelizier, Salim Kanoun, Anne Claire Gac, Stéphanie Guidez, Mohamed Touati, Kamel Laribi, Franck Morschhauser, Christophe Bonnet, Agathe Waultier-Rascalou, Frédérique Orsini-Piocelle, Marc André, Marguerite Fournier, Fabienne Morand, Alina Berriolo-Riedinger, Barbara Burroni, Diane Damotte, Alexandra Traverse-Glehen, Philippe Quittet, Olivier Casasnovas
Journal: Blood
Blood (2024) 143 (11): 983–995.
https://doi.org/10.1182/blood.2023021564
Published: 2024
Includes: Supplemental data
Journal Articles

Tazemetostat in Combination with R-CHOP in Patients with High-Risk, Frontline Follicular Lymphoma (Epi-RCHOP): A Phase II Study from the Lysa

Loic Ysebaert, Francois Lemonnier, Gabriel Brisou, Olivier Casasnovas, Gian Matteo Pica, Emmanuel Bachy, Ludovic Fouillet, Julie Abraham, Stephanie Guidez, Marc André, Guillaume Cartron, Romain Guieze, Sylvain Carras, Benoit Tessoulin, Roch Houot, Bohrane Slama, Christophe Bonnet, Luc-Matthieu Fornecker, Marie-Helene Delfau, Clementine Sarkozy, Camille Laurent, Vincent Ribrag, Franck Morschhauser
Journal: Blood
Blood (2023) 142 (Supplement 1): 297.
https://doi.org/10.1182/blood-2023-185057
Published: 2023
Journal Articles

Impact of Brentuximab Vedotin in Patients with Breast Implant-Associated Anaplastic Large Cell Lymphoma with Capsule Infiltration Requiring Chemotherapy

David Sibon, Jean Marc Schiano De Colella, Emmanuel Itti, Thu-Ha Dao, Lucie Oberic, Romain Ricci, Camille Laurent, Luc Xerri, Marc André, Emmanuelle Nicolas Virelizier, Christophe Bonnet, Alexandre Karangwa, Luc-Matthieu Fornecker, Emmanuel Bachy, Marie Bannier, Alexandra Traverse-Glehen, Youlia Kirova, Cyrielle de Lacheisserie, Romain Ould-Ammar, Patrick Fogarty, Nadia Amara, Virginie Fataccioli, Hervé Tilly, Lionel Tortolano, Romain Bosc, Fabien Le Bras, Philippe Gaulard, Corinne Haioun
Journal: Blood
Blood (2023) 142 (Supplement 1): 4439.
https://doi.org/10.1182/blood-2023-188896
Published: 2023
Journal Articles

Verlen, “Very Elderly Rituximab Associated to Lenalidomide - Tafasitamab Combination in Frontline DLBCL Patients”, a Phase II Open-Label Study Evaluating Efficacy of Lenalinomide and Tafasitamab Combination Associated to Rituximab in Frontline Diffuse Large B-Cell Lymphoma Patients of 80 y/o or Older from the Lysa Group

Benoit Tessoulin, Julien Depaus, Pierre Feugier, Ludovic Fouillet, Julie Abraham, Sandy Amorin, Fabrice Jardin, Franck Morschhauser, Catherine Thieblemont, François-Xavier Gros, Bertrand Joly, Hacene Zerazhi, Sophie Bernard, Adrien Chauchet, Stéphane Vigouroux, Christophe Bonnet, Sarah Bailly, Steven Le Gouill
Journal: Blood
Blood (2023) 142 (Supplement 1): 3094.
https://doi.org/10.1182/blood-2023-173265
Published: 2023
Journal Articles

Results of the Phase II of Epirchop Study, Evaluating the Efficacy of Tazemetostat in Combination with R-CHOP in Elderly Newly Diagnosed Diffuse Large B Cell Lymphoma (DLBCL): A Lysa Study

Clementine Sarkozy, Thierry Jo Molina, Roch Houot, Sydney Dubois, Gian Matteo Pica, Philippe Ruminy, Charles Herbaux, Thomas Gastinne, Corinne Haioun, Stephanie Guidez, Christophe Bonnet, Marc Andre, Liana Vereseza, Choquet Sylvain, Loic Ysebaert, Emmanuel Bachy, Fabrice Jardin, Franck Morschhauser, Vincent Ribrag
Journal: Blood
Blood (2023) 142 (Supplement 1): 853.
https://doi.org/10.1182/blood-2023-174607
Published: 2023
Journal Articles

Addition of Brentuximab Vedotin to Gemcitabine in Relapsed or Refractory T-Cell Lymphoma: Final Analysis of a Lysa Multicenter, Phase II Study. "the TOTAL Trial"

Olivier Tournilhac, Solene Lecolant, Maya Hacini, Krimo Bouabdallah, Sebastien Bailly, Kamel Laribi, Thibaut Belmondo, Marie Maerevoet, Loic Ysebaert, Stéphanie Guidez, Steven Le Gouill, Christophe Bonnet, Marc Andre, Jehan Dupuis, Catherine Thieblemont, Emmanuel Bachy, Nicolas Daguindau, Franck Morschhauser, Sabine Tricot, Pierre Feugier, Anne Banos, Thierry Lamy, Adrien Chauchet, Emmanuel Gyan, Guillaume Cartron, Hassan Farhat, Vincent Camus, Bernard Drenou, Hacene Zerazhi, David Sibon, Emmanuelle Nicolas-Virelizier, Caroline Delette, Sylvia Snauwaert, Nicole Straetmans, Richard Delarue, Marie Parrens, Samuel Griolet, Philippe Gaulard, Marie-Helene Delfau-Larue, Laurence De Leval, Gandhi Laurent Damaj
Journal: Blood
Blood (2022) 140 (Supplement 1): 2302–2305.
https://doi.org/10.1182/blood-2022-165217
Published: 2022
Journal Articles

Breast Implant Associated-Anaplastic Large-Cell Lymphoma (BIA-ALCL): Data Based on the Lymphoma Study Association (LYSA) Registry. Promising Results of Brentuximab Vedotin Combined with Cyclophosphamide, Doxorubicin and Prednisone (BV-CHP) As First Line Treatment for Patient Requiring Chemotherapy

Fabien Le Bras, Jean Marc Schiano De Colella, Lucie Oberic, Emmanuel Itti, Thua-Ha Dao, Camille Laurent, Luc Xerri, Emmanuel Bachy, Alexandra Traverse-Glehen, Christophe Bonnet, Marc André, Luc Mathieu Fornecker, Marie Bannier, Bohrane Slama, Youlia Kirova, Emmanuelle Nicolas-Virelizier, Manon Croix, Patrick Fogarty, Nadia Amara, Virginie Fataccioli, Romain Ricci, Hervé Tilly, Lionel Tortolano, Romain Bosc, Philippe Gaulard, Corinne Haioun
Journal: Blood
Blood (2021) 138 (Supplement 1): 1387.
https://doi.org/10.1182/blood-2021-150478
Published: 2021
Journal Articles

Salvage Therapy with Brentuximab-Vedotin and Bendamustine for Patients with Relapsed/Refractory T Cell Lymphoma. a Multicenter and Retrospective Study

Krimo Bouabdallah, Raphaëlle Aubrais, Loïc Chartier, Charles Herbaux, Anne Banos, Pauline Brice, Marlene Ochmann, David Sibon, Jean Marc Schiano De Colella, Thomas Cluzeau, Kamel Laribi, Ronan Le Calloch, Mathieu Bellal, Nicolas Daguindau, Sandy Amorim, Kossi Agbetiafa, Adrien Chauchet, Marwa Hammami, Eric Durot, Christophe Bonnet, Margot Robles, Ludovic Fouillet, Fontanet Bijou, Olivier Tournilhac, Philippe Gaulard, Marie Parrens, Noel-Jean Milpied, Gandhi Laurent Damaj
Journal: Blood
Blood (2021) 138 (Supplement 1): 620.
https://doi.org/10.1182/blood-2021-150953
Published: 2021
Journal Articles

Final Analysis of a Prospective Multicenter Phase II Trial of the Lymphoma Study Association (LYSA) Using Prednisone, Vinblastine, Doxorubicin and Bendamustine (PVAB) Regimen in First Line Therapy for Patients over 60 Years with Advanced-Stage Classical Hodgkin Lymphoma

Herve Ghesquieres, Rene-Olivier Casasnovas, Emmanuelle Nicolas-Virelizier, Salim Kanoun, Gandhi Laurent Damaj, Vincent Delwail, Arnaud Jaccard, Kamel Laribi, Franck Morschhauser, Christophe Bonnet, Agathe Waultier, Frederique Orsini-Piocelle, Marc Andre, Marguerite Fournier, Fabienne Morand, Alina Berriolo-Riedinger, Diane Damotte, Alexandra Traverse-Glehen, Philippe Quittet, Pauline Brice
Journal: Blood
Blood (2021) 138 (Supplement 1): 1370.
https://doi.org/10.1182/blood-2021-152346
Published: 2021
Journal Articles

Obinutuzumab vs rituximab for advanced DLBCL: a PET-guided and randomized phase 3 study by LYSA

Clinical Trials & Observations
Steven Le Gouill, Hervé Ghesquières, Lucie Oberic, Franck Morschhauser, Hervé Tilly, Vincent Ribrag, Thierry Lamy, Catherine Thieblemont, Hervé Maisonneuve, Rémy Gressin, Krimo Bouhabdallah, Corinne Haioun, Gandhi Damaj, Luc Fornecker, Réda Bouhabdallah, Pierre Feugier, David Sibon, Guillaume Cartron, Christophe Bonnet, Marc André, Loic Chartier, Philippe Ruminy, Françoise Kraeber-Bodéré, Caroline Bodet-Milin, Alina Berriolo-Riedinger, Josette Brière, Jean-Philippe Jais, Thierry Jo Molina, Emmanuel Itti, René-Olivier Casasnovas
Journal: Blood
Blood (2021) 137 (17): 2307–2320.
https://doi.org/10.1182/blood.2020008750
Published: 2021
Includes: Supplemental data
Journal Articles

R-CHOP14 As a Standard of Care in Primary Mediastinal B Cell Lymphoma: A 10-YEARS Experience of Lysa Centers

Vincent Camus, Alina Berriolo-Riedinger, Justine Lequesne, David Tonnelet, MD, Pierre Decazes, Cédric Rossi, MD PhD, Pierre Sesques, MD, Corinne Haioun, MD PhD, Eric Durot, MD, Alexandre Willaume, Martin Gauthier, Marie-Pierre Moles, MD, Chloe Antier, Julien Lazarovici, MD, Helene Monjanel, Sophie Bernard, Magalie Tardy, Caroline Besson, MDPhD, Laure Lebras, MD, Choquet Sylvain, Katell Le Du, MD, Christophe Bonnet, MD, Sarah Bailly, MD, Damaj Gandhi Laurent, MD PhD, Kamel Laribi, MD, Herve Maisonneuve, MD, Roch Houot, MDPhD, Adrien Chauchet, MD, Fabrice Jardin, MD PhD, Stephanie Becker, MD, Herve Tilly, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–21.
https://doi.org/10.1182/blood-2020-136600
Published: 2020
Journal Articles

Prednisone, Vinblastine, Doxorubicin and Bendamustine (PVAB) Regimen in First Line Therapy for Older Patients with Advanced-Stage Classical Hodgkin Lymphoma: Results of a Prospective Multicenter Phase II Trial of the Lymphoma Study Association (LYSA)

Herve Ghesquieres, MD PhD, Olivier Casasnovas, MD, Emmanuelle Nicolas-Virelizier, MD, Damaj Gandhi Laurent, MD PhD, Vincent Delwail, MD, Mohamed Touati, MD, Katell Le Du, MD, Franck Morschhauser, MD PhD, Christophe Bonnet, MD, Agathe Waultier-Rascalou, MD, Frederique Orsini-Piocelle, MD, Marc André, Myriam Ben Boutieb, Fabienne Morand, Diane Damotte, MD PhD, Alexandra Traverse-Glehen, MD PhD, Philippe Quittet, MD, Pauline Brice
Journal: Blood
Blood (2019) 134 (Supplement_1): 2832.
https://doi.org/10.1182/blood-2019-129016
Published: 2019
Journal Articles

Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL): The Lymphoma Study Association (LYSA) Registry Data

Fabien Le Bras, Philippe Gaulard, MD PhD, Marc Andre, MD, Corinne Haioun, MD PhD, Romain Bosc, MD PhD, Camille Laurent, MD PhD, Lionel Tortelano, PD, Thua-Ha Dao, MD, Emmanuel Itti, MD PhD, Caroline Malhaire, MD, Schiano de Colella Jean Marc, MD, Marie Bannier, MD, Emmanuel Bachy, MD PhD, Borhane Slama, MD, Luc Mathieu Fornecker, MD PhD, Lucie Oberic, MD, Alexandra Traverse-Glehen, MD PhD, Manon Croix, Julie Bonnefoy, Patrick Fogarty, Feriel Bouabbas, Nadia Amara, Virginie Fataccioli, PhD, Romain Ricci, Tania Cassubie-Mercier, Youlia Kirova, MD, Fabien Reyal, Herve Tilly, MD PhD, Emmanuelle Nicolas-Virelizier, MD, Luc Xerri, MD PhD, Christophe Bonnet, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4021.
https://doi.org/10.1182/blood-2019-129123
Published: 2019
Journal Articles

Obinutuzumab Versus Rituximab in Combination with ACVBP-14 or CHOP-14 Following a PET-Driven Strategy in Aa-IPI 1-3 DLBCL Patients (< 60 years): Third Planned Interim and Final Analyses of the Gained Trial

Rene-Olivier Casasnovas, MD, Gilles Andre Salles, MD PhD, Lucie Oberic, MD, Caroline Bodet-Milin, Josette Briere, MD, Franck Morschhauser, MD PhD, Herve Tilly, Vincent Ribrag, MD, Thierry Lamy, Pr, MD PhD, Catherine Thieblemont, MD PhD, Herve Maisonneuve, MD, Remy Gressin, MD, Krimo Bouabdallah, MD, Corinne Haioun, Gandhi Damaj, MD, Luc Mathieu Fornecker, Reda Bouabdallah, MD, Pierre Feugier, MD, Richard Delarue, MD, Anna Schmitt, Christophe Bonnet, MD PhD, Guillaume Cartron, Jean-Philippe Jais, MD PhD, Alina Berriolo-Riedinger, MD, Thierry Jo Molina, MDPhD, Emmanuel Itti, MD PhD, Steven Le Gouill, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 190.
https://doi.org/10.1182/blood.V130.Suppl_1.190.190
Published: 2017
Journal Articles

PET-Based Response after 2 Cycles of Brentuximab Vedotin in Combination with AVD for First-Line Treatment of Unfavorable Early-Stage Hodgkin Lymphoma: First Analysis of the Primary Endpoint of Breach, a Randomized Phase II Trial of Lysa-FIL-EORTC Intergroup

Luc-Matthieu Fornecker, Julien Lazarovici, MD, Igor Aurer, PhD, Rene-Olivier Casasnovas, MD, Anne-Claire Gac, Christophe Bonnet, MD PhD, Krimo Bouabdallah, MD, Aurore Perrot, MD, Lena Specht, Mohamed Touati, Jean Claude Eisenmann, Cecile Borel, MD, Aspasia Stamatoullas, MD, Emmanuelle Nicolas-Virelizier, MD, Laurent Pascal, Pieternella Lugtenburg, Monica Bellei, MSc, PhD, Alexandra traverse-Glehen, MD PhD, Christiane Copie, MDPhD, Martin Hutchings, MD PhD, Annibale Versari, Michel Meignan, Massimo Federico, Marc Andre, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 736.
https://doi.org/10.1182/blood.V130.Suppl_1.736.736
Published: 2017
Journal Articles

A Phase II LYSA Study of Obinutuzumab Combined with Lenalidomide for Relapsed or Refractory Aggressive B-Cell Lymphoma

Franck Morschhauser, MD PhD, Guillaume Cartron, MD PhD, Gilles A. Salles, Fontanet Bijou, MD, Christophe Fruchart, MD, Krimo Bouabdallah, MD, Pierre Feugier, MD PhD, Steven Le Gouill, MD PhD, Hervé Tilly, MD PhD, Cecile moluçon-Chabrot, MD, Marie Maerevoet, MD, Rene-Olivier Casasnovas, MD, Eric W Van Den Neste, MD PhD, Pierre Zachee, Koen Van Eygen, MD, Achiel Van Hoof, MD, Christophe Bonnet, MD PhD, Corinne Haioun, MD, Marc Andre, MD, Luc Xerri, MD PhD, Roch Houot, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4202.
https://doi.org/10.1182/blood.V128.22.4202.4202
Published: 2016
Journal Articles

Ibrutinib in Association with R-DHAP/Ox for Patients with Relapsed/Refractory B-Cell Lymphoma: Preliminary Results of the Biblos Phase Ib Lysa Study

Christophe Bonnet, MD PhD, Thierry Lamy, MD PhD, Christophe Fruchart, MD, Steven Le Gouill, MD PhD, Katharina Gunzer, MD, Thomas Gastinne, MD, Fabrice Jardin, MD PhD, Lionel Karlin, MD, Roch Houot, MD PhD, Jehan Dupuis, MD, Hervé Tilly, MD PhD, Gilles A. Salles
Journal: Blood
Blood (2016) 128 (22): 5384.
https://doi.org/10.1182/blood.V128.22.5384.5384
Published: 2016
Journal Articles

Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell–derived lymphomas

David Vallois, Maria Pamela D. Dobay, Ryan D. Morin, François Lemonnier, Edoardo Missiaglia, Mélanie Juilland, Justyna Iwaszkiewicz, Virginie Fataccioli, Bettina Bisig, Annalisa Roberti, Jasleen Grewal, Julie Bruneau, Bettina Fabiani, Antoine Martin, Christophe Bonnet, Olivier Michielin, Jean-Philippe Jais, Martin Figeac, Olivier A. Bernard, Mauro Delorenzi, Corinne Haioun, Olivier Tournilhac, Margot Thome, Randy D. Gascoyne, Philippe Gaulard, Laurence de Leval
Journal: Blood
Blood (2016) 128 (11): 1490–1502.
https://doi.org/10.1182/blood-2016-02-698977
Published: 2016
Includes: Supplemental data
Journal Articles

Long-Term Safety Follow-up of a Randomized Trial of Darbepoetin Alpha and Intravenous Iron Following Autologous Hematopoietic Cell Transplantation

Aurélie Jaspers, MD, Frederic Baron, MD PhD, Johan Maertens, MD PhD, Bernard J. M. De Prijck, MD, Henri (Rik) Schots, MDPhD, Christophe Bonnet, MD PhD, Kaoutar Hafraoui, MD, Evelyne Willems, MD PhD, Sophie Servais, MD PhD, Georges Fillet, MD PhD, Yves Beguin, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3948.
https://doi.org/10.1182/blood.V124.21.3948.3948
Published: 2014